Stock listing

ALVAL Stock Price, News, Filings & Events — Valbiotis Sa

Selected listing: ALVAL · EURONEXT · EUR · FR

This page tracks Valbiotis Sa's ALVAL:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALVAL:EURONEXT. ALVAL:EURONEXT is the stock-level entry point for investors researching Valbiotis Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Valbiotis SA is a public company listed on the French market under the ticker ALVAL, with a market capitalization of approximately €32.07 million. The company focuses on the development of innovative solutions for the prevention and management of metabolic diseases. Valbiotis is committed to advancing research and delivering products that address significant health challenges.

ALVAL:EURONEXTEURFRUpdated September 12, 2026
Valbiotis Sa logo
Ticker
ALVAL:EURONEXT
Asset type
Stock
Market cap
$33.2M
Sector
Health Technology
Industry
Biotechnology
Exchange
EURONEXT
Currency
EUR

Valbiotis Sa ALVAL:EURONEXT stock context

This page tracks Valbiotis Sa's ALVAL:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALVAL:EURONEXT. ALVAL:EURONEXT is the stock-level entry point for investors researching Valbiotis Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Valbiotis SA is a public company listed on the French market under the ticker ALVAL, with a market capitalization of approximately €32.07 million. The company focuses on the development of innovative solutions for the prevention and management of metabolic diseases. Valbiotis is committed to advancing research and delivering products that address significant health challenges.

Latest news from Valbiotis Sa

All Valbiotis Sa news →

Research Valbiotis Sa

Alternate listings